CLICK HERE FOR ORIGINAL POST was originally published on this website

Condition:   Fibrodysplasia Ossificans Progressiva
Interventions:   Drug: REGN2477;   Drug: Matching placebo
Sponsor:   Regeneron Pharmaceuticals
Not yet recruiting – verified June 2017